Literature DB >> 19092787

Does comorbidity affect the benefit of intensive glycemic control in older patients with type 2 diabetes mellitus?

Christopher D Saudek1, Rita R Kalyani.   

Abstract

Entities:  

Year:  2008        PMID： 19092787     DOI： 10.1038/ncpendmet1041

Source DB:  PubMed          Journal:  Nat Clin Pract Endocrinol Metab        ISSN： 1745-8366


× No keyword cloud information.
  6 in total

1.  Standards of medical care in diabetes--2008.

Authors: 
Journal:  Diabetes Care       Date:  2008-01       Impact factor: 19.112

2.  Model of complications of NIDDM. I. Model construction and assumptions.

Authors:  R C Eastman; J C Javitt; W H Herman; E J Dasbach; A S Zbrozek; F Dong; D Manninen; S A Garfield; C Copley-Merriman; W Maier; J F Eastman; J Kotsanos; C C Cowie; M Harris
Journal:  Diabetes Care       Date:  1997-05       Impact factor: 19.112

3.  A comparison of the study populations in the Diabetes Control and Complications Trial and the Wisconsin Epidemiologic Study of Diabetic Retinopathy.

Authors:  R Klein; S Moss
Journal:  Arch Intern Med       Date:  1995-04-10

4.  Effects of intensive glucose lowering in type 2 diabetes.

Authors:  Hertzel C Gerstein; Michael E Miller; Robert P Byington; David C Goff; J Thomas Bigger; John B Buse; William C Cushman; Saul Genuth; Faramarz Ismail-Beigi; Richard H Grimm; Jeffrey L Probstfield; Denise G Simons-Morton; William T Friedewald
Journal:  N Engl J Med       Date:  2008-06-06       Impact factor: 91.245

5.  The effect of comorbid illness and functional status on the expected benefits of intensive glucose control in older patients with type 2 diabetes: a decision analysis.

Authors:  Elbert S Huang; Qi Zhang; Niren Gandra; Marshall H Chin; David O Meltzer
Journal:  Ann Intern Med       Date:  2008-07-01       Impact factor: 25.391

6.  Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.

Authors: 
Journal:  Lancet       Date:  1998-09-12       Impact factor: 79.321
  6 in total
  1 in total

Review 1.  The clinical use of hemoglobin A1c.

Authors:  Christopher D Saudek; Jessica C Brick
Journal:  J Diabetes Sci Technol       Date:  2009-07-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.